VERIFIEDET Finance·22 Jul 2026neutral

Dr Reddy’s aims to resume semaglutide supply by November after API fix

AI Summary

·Dr Reddy's anticipates resuming semaglutide supplies by November following the resolution of quality issues.
·The company has identified the root cause of the API problem and plans to implement corrective actions by September.
·Dr Reddy's expects to supply millions of semaglutide units within the current fiscal year.